Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
The primary outcome is symptom severity at the end of the trial .This will be determined using the Clinician Administered PTSD Scale (CAPS), a scale with established reliability and good psychometric properties.
21 Years to 65 Years (Adult)
March 4, 2009
May 24, 2016
Sheba Medical Center Ramat-Gan, Israel
† Study has passed its completion date and status has not been verified in more than two years.